Publication | Open Access

Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells

Tumor BiologyBreast OncologyMedicineReceptor Tyrosine KinaseBreast Cancer CellsImmunologyCancer Cell BiologyBreast CancerCancer BiologyAtypical Nf-κb ActivationAnti-cancer AgentOncologyCell BiologyCell SignalingC-abl Kinase ActivityCancer Research